SEC Form 4 · accession 0000921895-16-004701
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
May 25, 2016
Accepted (ET)
May 26, 2016 · 5:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 25, 2016 | S | 26,000 | $1.90 | D | 5,427,313 | D | |
| Common Stock | May 25, 2016 | S | 400 | $1.9025 | D | 5,426,913 | D | |
| Common Stock | May 25, 2016 | S | 5,300 | $1.905 | D | 5,421,613 | D | |
| Common Stock | May 25, 2016 | S | 4,600 | $1.91 | D | 5,417,013 | D | |
| Common Stock | May 25, 2016 | S | 100 | $1.92 | D | 5,416,913 | D |
Table II — derivative securities
No Table II lines on this filing.